drug · antibody drug conjugate
patient view →brentuximab vedotin
Phase 2updated 2mo agoby $PFE PFIZER INC🔗 ChEMBL
Phase 2community read0 votes
Antibody drug conjugate drug with a maximum clinical stage of Approval (across all indications), with 4 approved and 18 investigational indications.
indications
indications
DLBCL
targets
TubulinTumor necrosis factor receptor superfamily member 8
all catalysts(1)
phase 1 completion · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that